Acetaminophen And Codeine
NDC Package 43353-010-45

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Acetaminophen And Codeine is phosphate Tablets, USP are indicated for the relief of mild to moderately severe pain. Marketed by Aphena Pharma Solutions - Tennessee, Llc, this product is identified by NDC 43353-010 and is authorized under FDA application ANDA040779.

Identification & Billing

NDC Package Code
43353-010-45
Package Description
45 TABLET in 1 BOTTLE
Product Code
11-Digit Billing Format
43353001045
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
45 EA
RxNorm Crosswalk
  • RxCUI: 993781 - codeine phosphate 30 MG / acetaminophen 300 MG Oral Tablet
  • RxCUI: 993781 - acetaminophen 300 MG / codeine phosphate 30 MG Oral Tablet
  • RxCUI: 993781 - APAP 300 MG / codeine phosphate 30 MG Oral Tablet

Clinical Specifications

Proprietary Name
Acetaminophen And Codeine
Dosage Form
-
Usage Information
Acetaminophen and Codeine Phosphate Tablets, USP are indicated for the relief of mild to moderately severe pain.

Regulatory & Marketing

Labeler Name
Aphena Pharma Solutions - Tennessee, Llc
FDA Application #
ANDA040779
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
05-29-2008
Listing Expiration
12-31-2022
Exclude Flag
I
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (43353-010). Click a package code to view its specific billing and regulatory data.

40 TABLET in 1 BOTTLE
50 TABLET in 1 BOTTLE
90 TABLET in 1 BOTTLE
120 TABLET in 1 BOTTLE
150 TABLET in 1 BOTTLE
240 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 43353-010-45 identifies a specific commercial package of 45 tablet in 1 bottle of Acetaminophen And Codeine, labeled by Aphena Pharma Solutions - Tennessee, Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 45 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Aphena Pharma Solutions - Tennessee, Llc on May 29, 2008. The current certification is valid through December 31, 2022.

How is this Aphena Pharma Solutions - Tennessee, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 43353001045. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 45 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
43353-010-45
11-Digit CMS (5-4-2)
43353-0010-45

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.